scholarly journals Evaluation of a novel non-invasive preimplantation genetic screening approach

PLoS ONE ◽  
2018 ◽  
Vol 13 (5) ◽  
pp. e0197262 ◽  
Author(s):  
Valeriy Kuznyetsov ◽  
Svetlana Madjunkova ◽  
Ran Antes ◽  
Rina Abramov ◽  
Gelareh Motamedi ◽  
...  
2017 ◽  
Vol 108 (3) ◽  
pp. e277 ◽  
Author(s):  
V. Kuznyetsov ◽  
S. Madjunkova ◽  
R. Antes ◽  
R. Abramov ◽  
G. Motamedi ◽  
...  

2016 ◽  
Vol 69 (7-8) ◽  
pp. 241-246
Author(s):  
Artur Bjelica ◽  
Srna Subanovic

Introduction. Since reproductive technologies are becoming increasingly popular among the couples with infertility problem, and having in mind that the success rate is still low, the clinicians tend to transfer more embryos in order to increase the probability of success. However, such a strategy increases the risk of multiple pregnancy, which brings about numerous risks to the health of both the mother and children. Therefore, an elective single-embryo transfer is set as imperative, which, on the other hand, would not be possible without selection and evaluation of the quality of embryos. Assessment of Embryo Quality. Embryos can be selected by various methods, from non-invasive to invasive methods. In non-invasive methods, the embryos are selected by their morphology or by the techniques based on the analysis of molecular components - analyses of the level of proteomes or metabolomes. A more detailed monitoring of the kinetics of the embryo development can be related to the introduction of time-lapse imaging and monitoring systems into laboratory practice. The invasive methods encompass the techniques such as preimplantation genetic diagnosis and preimplantation genetic screening. In preimplantation genetic diagnosis, the assisted reproduction technologies cycle is approached for the genetic reasons, whereas preimplantation genetic screening is used to enhance the success rate of the assisted reproduction cycles. Conclusion. In this paper we have shown that the application of elective single-embryo transfer requires the selection and assessment of the quality of embryos by the methods that have been developed in the last four decades, and still need further improvements.


2021 ◽  
Author(s):  
Kaylin O’Brien

Through cellular biopsy of a developing embryo, genetic testing can be performed as part of the embryo selection phase of an in vitro fertilization (IVF) cycle. Preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) allow embryos to be tested for genetic conditions on a chromosome and gene level, respectively, prior to implantation in the uterus and prior to pregnancy. Included in this review are indications for PGS and PGD, the biopsy and diagnostic methods that are most frequently utilized, advances in recent non-invasive technologies, and potential impacts that PGS/PGD and IVF may have on developing embryos. This review contains 5 figures, 1 table, and 53 references.  Keywords: Preimplantation genetic diagnosis, preimplantation genetic screening, blastocyst biopsy, blastomere biopsy, advances in PGS/PGD, indications for PGS/PGD, non-invasive embryo biopsy, infertility


Sign in / Sign up

Export Citation Format

Share Document